Inaugural Lecture: Professor Richard Scheltema
5:00pm - 7:00pm /
Wednesday 26th February 2025
Type: Lecture /
Category: Research
/ Series: Institute of Systems, Molecular and Integrative Biology
- Jackie Henderson
- Admission: Free
- Event website
- Book now
Add this event to my calendar
Click on "Create a calendar file" and your browser will download a .ics file for this event.
Microsoft Outlook: Download the file, double-click it to open it in Outlook, then click on "Save & Close" to save it to your calendar. If that doesn't work go into Outlook, click on the File tab, then on Open & Export, then Open Calendar. Select your .ics file then click on "Save & Close".
Google Calendar: download the file, then go into your calendar. On the left where it says "Other calendars" click on the arrow icon and then click on Import calendar. Click on Browse and select the .ics file, then click on Import.
Apple Calendar: The file may open automatically with an option to save it to your calendar. If not, download the file, then you can either drag it to Calendar or import the file by going to File >Import > Import and choosing the .ics file.
Inaugural Lecture: 'Using proteomics to visualise the intricate protein landscape'
Professor Richard Scheltema, Department of Biochemistry, Cell and Systems Biology
Professor Richard Scheltema is an analytical scientist whose work integrates mass spectrometry, bioinformatics, and chemistry to explore the complex dynamics of proteins. In 2024, Richard joined the University of Liverpool to further his research and co-direct the Centre for Proteome Research.
Richard earned his PhD at the University of Groningen, Netherlands, focusing on the then-novel Orbitrap mass spectrometry platform. Richard’s work, for example, illuminated mechanisms of drug resistance in parasites like Leishmania. He continued as a postdoctoral researcher at the Max Planck Institute for Biochemistry under Professor Matthias Mann, where he contributed to pioneering developments in Orbitrap mass spectrometry and applied it to structural biology. Subsequently, as an assistant and associate professor in Professor Albert Heck’s lab, he combined new chemistry with advanced mass spectrometry techniques to investigate protein complexes, with the most recent an insulin-inhibiting receptor with therapeutic potential for combating insulin resistance in beta cells.
At Liverpool, Richard's research centres on developing and applying cutting-edge mass spectrometry workflows to uncover molecular changes in health, disease, and aging, aiming to identify novel therapeutic targets. In this lecture, he will share highlights from his scientific journey, his discoveries, and how his work can uncover fundamental insights that can be translated into practical applications for advancing human health.
The lecture will take place at 17:00, followed by a networking drinks reception.
Professor Richard Scheltema, Department of Biochemistry, Cell and Systems Biology
Professor Richard Scheltema is an analytical scientist whose work integrates mass spectrometry, bioinformatics, and chemistry to explore the complex dynamics of proteins. In 2024, Richard joined the University of Liverpool to further his research and co-direct the Centre for Proteome Research.
Richard earned his PhD at the University of Groningen, Netherlands, focusing on the then-novel Orbitrap mass spectrometry platform. Richard’s work, for example, illuminated mechanisms of drug resistance in parasites like Leishmania. He continued as a postdoctoral researcher at the Max Planck Institute for Biochemistry under Professor Matthias Mann, where he contributed to pioneering developments in Orbitrap mass spectrometry and applied it to structural biology. Subsequently, as an assistant and associate professor in Professor Albert Heck’s lab, he combined new chemistry with advanced mass spectrometry techniques to investigate protein complexes, with the most recent an insulin-inhibiting receptor with therapeutic potential for combating insulin resistance in beta cells.
At Liverpool, Richard's research centres on developing and applying cutting-edge mass spectrometry workflows to uncover molecular changes in health, disease, and aging, aiming to identify novel therapeutic targets. In this lecture, he will share highlights from his scientific journey, his discoveries, and how his work can uncover fundamental insights that can be translated into practical applications for advancing human health.
The lecture will take place at 17:00, followed by a networking drinks reception.